Double maintains 2 strategies that include SDGR - Schrödinger, Inc.
Current Value
$21.421 Year Return
Current Value
$21.421 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -42.08% | $315.93M | 1.43% |
TAIL | -40.44% | $94.86M | 0.59% |
VIXY | -39.82% | $184.73M | 0.85% |
XONE | -25.34% | $628.85M | 0.03% |
SHYM | -24.54% | $355.86M | 0.35% |
SPTS | -22.42% | $5.77B | 0.03% |
AGZ | -21.24% | $609.66M | 0.2% |
ULST | -20.35% | $592.38M | 0.2% |
VGSH | -19.44% | $22.68B | 0.03% |
CGSM | -18.94% | $716.74M | 0.25% |
IBTH | -18.60% | $1.62B | 0.07% |
UTWO | -18.57% | $376.33M | 0.15% |
BSMW | -18.55% | $107.49M | 0.18% |
IBTG | -18.41% | $1.92B | 0.07% |
IVOL | -17.97% | $342.69M | 1.02% |
SCHO | -17.89% | $10.98B | 0.03% |
STXT | -17.52% | $128.32M | 0.49% |
IBTJ | -17.23% | $686.15M | 0.07% |
IEI | -16.81% | $15.53B | 0.15% |
IBTI | -16.80% | $1.06B | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ED | -18.15% | $36.42B | +10.51% | 3.36% |
CBOE | -16.21% | $24.55B | +38.09% | 1.08% |
SO | -11.85% | $102.50B | +16.78% | 3.13% |
AEP | -11.42% | $56.65B | +16.73% | 3.49% |
CME | -11.34% | $99.17B | +44.04% | 1.75% |
NEE | -10.57% | $153.66B | -0.08% | 2.93% |
AWK | -10.48% | $27.82B | +4.74% | 2.18% |
EXC | -10.35% | $44.05B | +23.53% | 3.60% |
T | -10.21% | $198.74B | +46.45% | 5.06% |
VZ | -9.58% | $177.21B | +1.77% | 8.05% |
MO | -9.44% | $98.62B | +24.36% | 7.00% |
VOD | -9.42% | $26.61B | +18.72% | 4.50% |
CMS | -7.79% | $21.10B | +16.29% | 3.01% |
AMT | -7.77% | $103.46B | +6.67% | 3.01% |
K | -7.19% | $27.64B | +40.17% | 2.86% |
DUK | -7.05% | $91.85B | +13.12% | 3.57% |
ZCMD | -6.89% | $28.54M | -8.87% | 0.00% |
TEF | -6.78% | $29.35B | +18.72% | 6.32% |
WEC | -6.47% | $33.73B | +31.54% | 3.27% |
D | -6.06% | $49.60B | +12.65% | 4.63% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ARKG | 66.59% | $1.03B | 0.75% |
GNOM | 60.24% | $46.47M | 0.5% |
XBI | 55.29% | $4.81B | 0.35% |
IWO | 53.22% | $11.77B | 0.24% |
IWC | 53.18% | $840.86M | 0.6% |
PTH | 52.84% | $96.25M | 0.6% |
KJUL | 51.73% | $159.39M | 0.79% |
ISCG | 51.29% | $688.57M | 0.06% |
IBB | 51.27% | $5.37B | 0.45% |
KOMP | 50.98% | $2.34B | 0.2% |
VTWO | 50.78% | $12.65B | 0.07% |
IWM | 50.77% | $65.64B | 0.19% |
IWMY | 50.56% | $120.43M | 1.02% |
VBK | 50.55% | $19.19B | 0.07% |
PBE | 50.09% | $226.91M | 0.58% |
VXF | 50.01% | $22.53B | 0.05% |
SCHA | 49.78% | $17.61B | 0.04% |
NUSC | 49.48% | $1.16B | 0.31% |
FINX | 49.47% | $311.04M | 0.68% |
IBUY | 49.34% | $154.68M | 0.65% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBD | 0.01% | $390.98M | 0.43% |
IBDZ | -0.03% | $363.32M | 0.1% |
PSQA | 0.04% | $36.49M | 0.2% |
BSCW | 0.04% | $931.45M | 0.1% |
BILZ | -0.08% | $851.85M | 0.14% |
UDN | -0.09% | $147.46M | 0.78% |
ICSH | -0.10% | $5.96B | 0.08% |
BWX | -0.13% | $1.53B | 0.35% |
JUCY | -0.15% | $256.50M | 0.6% |
PYLD | -0.26% | $6.03B | 0.69% |
NUAG | -0.39% | $58.25M | 0.19% |
CANE | -0.42% | $11.14M | 0.29% |
BLV | -0.50% | $5.58B | 0.03% |
IBDU | -0.50% | $2.68B | 0.1% |
BSCU | 0.51% | $1.65B | 0.1% |
BSCT | 0.57% | $2.12B | 0.1% |
VCSH | -0.61% | $34.12B | 0.03% |
WEAT | -0.62% | $123.28M | 0.28% |
SCHI | 0.62% | $8.65B | 0.03% |
IBDV | -0.66% | $1.90B | 0.1% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
DG | 0.15% | $24.71B | -14.69% | 2.10% |
CI | -0.29% | $82.49B | -7.43% | 1.90% |
CNC | 0.29% | $16.18B | -51.64% | 0.00% |
COR | -0.37% | $57.63B | +33.93% | 0.73% |
CIG.C | -0.45% | $2.68B | +23.72% | 0.00% |
CYCN | -0.46% | $11.40M | +5.03% | 0.00% |
PPL | 0.53% | $25.38B | +21.65% | 3.11% |
CWEN | -0.65% | $3.80B | +26.32% | 5.33% |
ES | -0.68% | $24.29B | +11.30% | 4.48% |
PG | -0.72% | $371.59B | -4.26% | 2.59% |
PEP | -0.76% | $186.58B | -17.00% | 4.07% |
PGR | 0.79% | $146.19B | +17.73% | 1.98% |
SBAC | 0.84% | $25.01B | +10.93% | 1.80% |
HCA | 0.88% | $91.01B | +19.15% | 0.74% |
EDU | 0.90% | $8.65B | -29.86% | 0.00% |
KVUE | 0.92% | $40.16B | +16.74% | 3.94% |
FENG | 0.92% | $12.15M | -37.33% | 0.00% |
ASPS | -0.94% | $152.11M | +47.41% | 0.00% |
CWEN.A | -1.05% | $3.59B | +29.45% | 5.66% |
SBRA | 1.09% | $4.37B | +17.46% | 6.53% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CERT | 64.50% | $1.87B | -23.94% | 0.00% |
SLP | 62.44% | $353.35M | -57.44% | 0.34% |
RXRX | 56.90% | $2.47B | -25.59% | 0.00% |
ABCL | 55.78% | $1.27B | +35.78% | 0.00% |
CRSP | 53.19% | $5.10B | +3.85% | 0.00% |
BEAM | 49.82% | $2.22B | -14.88% | 0.00% |
NTLA | 49.81% | $1.26B | -50.63% | 0.00% |
TWST | 48.85% | $2.30B | -26.70% | 0.00% |
RGEN | 47.72% | $7.53B | +6.21% | 0.00% |
DNA | 46.44% | $599.19M | -15.76% | 0.00% |
DNLI | 46.18% | $2.23B | -33.52% | 0.00% |
BIO | 45.97% | $7.07B | -12.06% | 0.00% |
PHR | 45.88% | $1.71B | +39.11% | 0.00% |
TXG | 45.50% | $1.58B | -25.72% | 0.00% |
GH | 45.44% | $6.35B | +71.14% | 0.00% |
ITT | 45.06% | $12.40B | +19.14% | 0.86% |
CYRX | 44.98% | $376.53M | +6.83% | 0.00% |
IDYA | 44.80% | $2.00B | -42.45% | 0.00% |
IQV | 44.73% | $28.64B | -24.57% | 0.00% |
ZYME | 44.48% | $959.66M | +38.40% | 0.00% |
Yahoo
Schrödinger, Inc. (NASDAQ:SDGR) is one of the 11 Best Mid-cap Healthcare Stocks to Buy According to Hedge Funds. Morgan Stanley assumed coverage on the company’s stock with an “Equalweight” rating and a price objective of $28.00, down from the prior target of $31.00, as reported by The Fly. As per the firm’s analyst, Schrödinger, Inc. (NASDAQ:SDGR) saw […]
Yahoo
The most talked about and market moving research calls around Wall Street are now in one place. Here are today’s research calls that investors need to know, as compiled by The Fly. Top 5 Upgrades: Needham upgraded Meta Platforms (META) to Hold from Underperform with no price target. Channel checks are driving upside to the firm’s estimates, but the firm remains on the sidelines with a Hold because the firm believes Meta’s strategy diffusion “wastes capital and adds risks” and the company’s margi
Yahoo
Schrödinger, Inc. (NASDAQ:SDGR) is one of the top 10 healthcare AI stocks to buy according to hedge funds. Schrödinger, Inc. (NASDAQ:SDGR) announced that its investigational drug SGR-1505 has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for the treatment of adults with Waldenström macroglobulinemia who have not responded to at least […]
Yahoo
Meta upgraded, PNC Financial downgraded: Wall Street's top analyst calls
Yahoo
Investing.com -- Morgan Stanley initiated coverage on three AI-integrated biotechnology firms, Absci, Schrodinger (NASDAQ:SDGR), and Recursion Pharmaceuticals, flagging divergent business models and upcoming catalysts in a sector under pressure.
Finnhub
NEW YORK, July 2, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Schrödinger, Inc. . Such investors are advised to contact Danielle Peyton at...